Overland Pharmaceuticals Employee Directory
Biotechnology ResearchShanghai, China11-50 Employees
Overland Pharmaceuticals is a biotechnology research company headquartered in Shanghai, China, with a workforce of 11 to 50 employees. The company is developing a portfolio of differentiated therapeutic candidates in oncology and autoimmune diseases, aiming to leverage its resources, network, and Asia-based biopharma expertise. It pursues a global approach to bringing innovative medicines to underserved patients in Asia and around the world. In 2023, the company announced a biologics license application related to ZYNLONTA. The company’s history includes leadership changes, with Xun Liu named chief technology officer in March 2022. In May 2026, Allogene Therapeutics terminated its regional licensing agreement with Overland and reclaimed full global rights to four allogeneic CAR T programs targeting BCMA, CD70, FLT3, and DLL3.